UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids

Nature medicine, 2015-11, Vol.21 (11), p.1364-1371

2015

Volltextzugriff (PDF)

Type-specific cell line models for type-specific ovarian cancer research

PloS one, 2013-09, Vol.8 (9), p.e72162-e72162

2013

Volltextzugriff (PDF)

Reproducibility of histological cell type in high-grade endometrial carcinoma

Modern pathology, 2013-12, Vol.26 (12), p.1594-1604

2013

Volltextzugriff (PDF)

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

PLoS medicine, 2008-12, Vol.5 (12), p.e232-e232

2008

Volltextzugriff (PDF)

Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics

Clinical cancer research, 2021-01, Vol.27 (1), p.150-157

2021

Volltextzugriff (PDF)

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

BMC cancer, 2017-09, Vol.17 (1), p.618-618, Article 618

2017

Volltextzugriff (PDF)

Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma

Modern pathology, 2015-10, Vol.28 (10), p.1383-1389

2015

Volltextzugriff (PDF)

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

Journal of translational medicine, 2012-02, Vol.10 (1), p.33-33, Article 33

2012

Volltextzugriff (PDF)

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

BMC cancer, 2009-12, Vol.9 (1), p.433-433, Article 433

2009

Volltextzugriff (PDF)

Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas

Neoplasia (New York, N.Y.), 2008-09, Vol.10 (9), p.1021-1027

2008

Volltextzugriff (PDF)

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

BMC cancer, 2008-01, Vol.8 (1), p.17-17, Article 17

2008

Volltextzugriff (PDF)

Quantification of ER/PR expression in ovarian low-grade serous carcinoma

Gynecologic oncology, 2013-02, Vol.128 (2), p.371-376

2013

Volltextzugriff (PDF)

Dynamics of leukocyte telomere length in pregnant women living with HIV, and HIV-negative pregnant women: A longitudinal observational study

PloS one, 2019-03, Vol.14 (3), p.e0212273-e0212273

2019

Volltextzugriff (PDF)

ARID1A /BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts

Human pathology, 2014-06, Vol.45 (6), p.1258-1268

2014

Volltextzugriff (PDF)

Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications

Gynecologic oncology, 2010-01, Vol.116 (1), p.50-56

2010

Volltextzugriff (PDF)

Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction

PloS one, 2016-04, Vol.11 (4), p.e0153844-e0153844

2016

Volltextzugriff (PDF)

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors

Modern pathology, 2013-09, Vol.26 (9), p.1255-1263

2013

Volltextzugriff (PDF)

Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non–small Cell Lung Cancer

The journal of histochemistry and cytochemistry, 2016-10, Vol.64 (10), p.587-600

2016

Volltextzugriff (PDF)

HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation

Archives of pathology & laboratory medicine (1976), 2014-11, Vol.138 (11), p.1495-1502

2014

Volltextzugriff (PDF)

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

Modern pathology, 2009-03, Vol.22 (3), p.469-475

2009

Volltextzugriff (PDF)

Advancing the Care of Pancreatic Cancer Patients: Moving Beyond Just Tumour Tissue

Biomarker Insights, 2021, Vol.16, p.117727192110498-11772719211049852

2021

Volltextzugriff (PDF)

Amplification of 11q13 in ovarian carcinoma

Genes chromosomes & cancer, 2008-06, Vol.47 (6), p.481-489

2008

Volltextzugriff (PDF)

The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma

Clinical & experimental metastasis, 2012-03, Vol.29 (3), p.239-252

2012

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(85)

Sprache

Englisch
(85)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids

Type-specific cell line models for type-specific ovarian cancer research

Reproducibility of histological cell type in high-grade endometrial carcinoma

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma

Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

Quantification of ER/PR expression in ovarian low-grade serous carcinoma

Dynamics of leukocyte telomere length in pregnant women living with HIV, and HIV-negative pregnant women: A longitudinal observational study

ARID1A /BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts

Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications

Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction

The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors

Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non–small Cell Lung Cancer

Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis

HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

Advancing the Care of Pancreatic Cancer Patients: Moving Beyond Just Tumour Tissue

Amplification of 11q13 in ovarian carcinoma

The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma

Aktive Filter

Suchergebnisse filtern